New gene therapy takes on tough pancreatic cancer
Disease control
Recruiting now
This early-stage trial tests a new cell-based gene therapy called RR001 given after chemotherapy for people with locally advanced pancreatic cancer that cannot be removed by surgery. The study aims to check safety and find the best dose in about 9 participants. It is not a cure, …
Phase: PHASE1, PHASE2 • Sponsor: EIR Biotherapies s.r.l. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC